Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3 Argatroban Intermediate High Purity
Manufacturer Supply Argatroban Related Intermediates:
Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3
N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2
3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4
Argatroban Monohydrate CAS 141396-28-3
Argatroban Anhydrous CAS 74863-84-6
| Dzina la Chemical | Ethyl (2R,4R) -4-Methyl-2-Piperidinecarboxylate |
| Mawu ofanana ndi mawu | Ethyl (2R,4R) -4-Methylpipecolate;(2R,4R) -4-Methyl-2-Piperidinecarboxylate;(2R,4R)-Ethyl 4-Methylpiperidine-2-Carboxylate;Ethyl-(2R,4R)-4-Methylpiperidine-2-Carboxylate |
| Nambala ya CAS | 74892-82-3 |
| Nambala ya CAT | RF-PI267 |
| Stock Status | Mu Stock, Kupanga Kukula Mpaka Matani |
| Molecular Formula | C9H17NO2 |
| Kulemera kwa Maselo | 171.24 |
| Mkhalidwe Wotumiza | Kutumizidwa Pansi pa Kutentha Kozungulira |
| Mtundu | Ruifu Chemical |
| Kanthu | Zofotokozera |
| Maonekedwe | Choyera ku Light Yellow Liquid |
| Diastereoisomer | ≤1.0% |
| Kuyera / Kusanthula Njira | ≥98.0% (GC) |
| Zitsulo Zolemera | ≤20ppm |
| Test Standard | Enterprise Standard |
| Kugwiritsa ntchito | Argatroban Intermediate (CAS 74863-84-6) |
Phukusi: Botolo, mbiya, 25kg / mbiya, kapena malinga ndi zofuna za kasitomala.
Mkhalidwe Wosungira:Sungani m'mitsuko yosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala, chinyezi ndi tizilombo towononga.
Shanghai Ruifu Chemical Co., Ltd. ndi amene amapanga ndi kugulitsa Ethyl (2R,4R) -4-Methyl-2-Piperidinecarboxylate (CAS: 74892-82-3) yokhala ndi khalidwe lapamwamba.Ethyl (2R,4R) -4-Methyl-2-Piperidinecarboxylate (CAS: 74892-82-3) ndi yapakatikati mwa kaphatikizidwe ka Argatroban Monohydrate (CAS 141396-28-3) kapena Argatroban (CAS 74863-84-6) ).
Argatroban Monohydrate ndi yeniyeni thrombin inhibitor, amene si heparin anticoagulant, kuteteza mapangidwe thrombi.Argatroban ndi anticoagulant yomwe ndi molekyulu yaying'ono yolunjika thrombin inhibitor.Mu 2000, argatroban adaloledwa ndi Food and Drug Administration (FDA) kuti ateteze kapena kuchiza thrombosis kwa odwala omwe ali ndi heparin-induced thrombocytopenia (HIT).
